febuxostat

The drug is used to treat chronic hyperuricemia in conditions accompanied by the deposition of urate crystals (specifically in the presence of tophi or gouty arthritis). The 120 mg dose is also indicated for the treatment and prevention of hyperuricemia in adults undergoing chemotherapy for hematological malignancies with a risk of tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: Pfizer France (bulk manufacturing and batch control)

The drug is used to treat chronic hyperuricemia in conditions accompanied by the deposition of urate crystals (specifically in the presence of tophi or gouty arthritis). Additionally, a 120 mg dose is used for the treatment and prevention of hyperuricemia in adults undergoing chemotherapy for hematological malignancies with a risk of tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: Pfizer France (bulk manufacturing and batch control)

The drug is used for the treatment of chronic hyperuricemia (elevated uric acid levels) accompanied by the deposition of urate crystals, particularly in the presence of tophi or gouty arthritis. It is also indicated for the prevention of hyperuricemia in adult patients undergoing chemotherapy for hematological malignancies with a risk of developing tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: Rontis Hellas Medical and Pharmaceutical Products C.A.

The drug is used for the treatment of chronic hyperuricemia (elevated uric acid levels) in gout, as well as for the prevention and treatment of hyperuricemia in adult patients undergoing chemotherapy for hematological malignancies with a risk of tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: Rontis Hellas Medical and Pharmaceutical Products C.A.

The drug is used to treat chronic hyperuricemia in conditions accompanied by urate crystal deposition (for example, in the presence of tophi or gouty arthritis). It is also used for the treatment and prevention of hyperuricemia in adults undergoing chemotherapy for hematological malignancies with a risk of tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: Dzhenefarm S.A.

The drug is used for the treatment of chronic hyperuricemia (elevated uric acid levels) in conditions accompanied by urate crystal deposition, particularly in the presence of tophi or gouty arthritis. It is also indicated for the prevention of hyperuricemia in adults undergoing chemotherapy for hematological malignancies with a risk of tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: Dzhenefarm S.A.

The drug is used to treat chronic hyperuricemia (elevated uric acid levels) in gout, as well as to prevent hyperuricemia in adults undergoing chemotherapy for hematological malignancies with a risk of tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: GenePharm SA

The drug is used to treat chronic hyperuricemia (elevated uric acid levels) in gout, as well as to prevent hyperuricemia in adult patients undergoing chemotherapy for hematological malignancies with a risk of tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: GenePharm SA

The drug is prescribed for the treatment of chronic hyperuricemia in patients with gout who do not respond to allopurinol or who cannot tolerate it.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: Mankind Pharma Limited, Unit-II

The drug is prescribed for the treatment of chronic hyperuricemia in patients with gout who do not respond to allopurinol or who cannot tolerate it.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: Mankind Pharma Limited, Unit-II

The drug is used for the treatment of chronic hyperuricemia (elevated uric acid levels) in gout, particularly in the presence of tophi or gouty arthritis. It is also indicated for adult patients undergoing chemotherapy for hematological malignancies to prevent tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: Macleods Pharmaceuticals Limited

The drug is used to treat chronic hyperuricemia (elevated uric acid levels) in gout, as well as to prevent hyperuricemia in adult patients undergoing chemotherapy for hematological malignancies with a risk of tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: Macleods Pharmaceuticals Limited

The drug is used for the treatment of chronic hyperuricemia in conditions accompanied by the deposition of urate crystals (specifically in the presence of tophi or gouty arthritis). Liquestia is also prescribed to adults for the treatment and prevention of hyperuricemia during chemotherapy for hematological malignancies with a risk of tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: JSC "Farmak" (manufacturing of products in bulk from manufacturer GeneFarma S.A., Greece)

The drug is used to treat chronic hyperuricemia (elevated uric acid levels) accompanied by the deposition of urate crystals, particularly in the presence of tophi or gouty arthritis. Liquestia is also prescribed to adults for the prevention of hyperuricemia during chemotherapy for hematological malignancies with a risk of developing tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: JSC "Farmak" (manufacturing of products in bulk from the manufacturer GenePharm S.A., Greece)

The drug is intended for the treatment of chronic hyperuricemia (elevated uric acid levels) in gout, as well as for the prevention and treatment of hyperuricemia in adults undergoing chemotherapy due to the risk of tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: Rontis Hellas Medical and Pharmaceutical Products S.A.

The drug is intended for the treatment of chronic hyperuricemia (elevated uric acid levels) in gout. Additionally, a 120 mg dose is used for the prevention and treatment of hyperuricemia in adults undergoing chemotherapy due to the risk of tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: Rontis Hellas Medical and Pharmaceutical Products S.A.

The drug is used for the treatment of chronic hyperuricemia (elevated uric acid levels) accompanied by urate crystal deposition, particularly in the presence of tophi or a history of gout. It is also prescribed to adults for the prevention of hyperuricemia during chemotherapy for hematological malignancies with a risk of tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: JSC "Kyiv Vitamin Plant"

The drug is used to treat chronic hyperuricemia (elevated uric acid levels) in conditions accompanied by urate crystal deposition, particularly in the presence of tophi or gouty arthritis. It is also prescribed to adults for the prevention of hyperuricemia during chemotherapy for hematological malignancies with a risk of tumor lysis syndrome.

Form: tablets, film-coated

ATC: M04AA03

Manufacturer: JSC "Kyiv Vitamin Plant"